共 30 条
[2]
Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure
[J].
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS,
1998, 91 (03)
:199-203
[3]
[Anonymous], 1994, CYTOKINES CELLULAR M
[7]
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
[J].
CIRCULATION,
2003, 107 (25)
:3133-3140
[10]
DREXLER H, 1995, AM J CARDIOL, V76, P13